The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Fecal Calprotectin Test-Global Market Insights and Sales Trends 2024
Synopsis
Fecal calprotectin test is a non-invasive clinical laboratory test that is used as a protein biomarker for the diagnosis of gastrointestinal disorders such as inflammatory bowel diseases, gastrointestinal infections, celiac disease, and colorectal cancer Calprotectin is a protein produced by the white blood cells. It is found in saliva, blood, stool, cerebrospinal fluid, and urine. Increase in level of calprotectin in stool is an indication of presence of gastrointestinal inflammation. Fecal calprotectin test is a quantitative measurement test that is usually carried out with the enzyme linked immunoassay (ELISA) technique. The test measures the level of inflammation in the bowel. Thus, it is inflammation specific and not disease specific. Fecal calprotectin test is primarily used as a protein biomarker in order to distinguish inflammatory bowel diseases such as Crohn s disease and ulcerative colitis from irritable bowel syndrome. This test also helps predict the relapse of the inflammatory bowel disease, therapeutic drug monitoring, and gastrointestinal disease prognosis.
The global Fecal Calprotectin Test market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Fecal Calprotectin Test in various end use industries. The expanding demands from the Hospitals, Diagnostic Laboratories, Academic & Research Institutes and Others, are propelling Fecal Calprotectin Test market. 1×96 Well, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 2×96 Well segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Fecal Calprotectin Test market, driven by demand from China, the second largest economy with some signs of stabilising, the Fecal Calprotectin Test market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Fecal Calprotectin Test, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Fecal Calprotectin Test market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Fecal Calprotectin Test market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Fecal Calprotectin Test sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Fecal Calprotectin Test covered in this report include Medixbiochemica, LifeSpan BioSciences, Inc, RayBiotech, Inc, Eagle Bioscience, Inc, Abbexa Ltd, Svar Life Science, Epitope Diagnostics, Inc and Alpha Laboratories, etc.
The global Fecal Calprotectin Test market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Medixbiochemica
LifeSpan BioSciences, Inc
RayBiotech, Inc
Eagle Bioscience, Inc
Abbexa Ltd
Svar Life Science
Epitope Diagnostics, Inc
Alpha Laboratories
Global Fecal Calprotectin Test market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Fecal Calprotectin Test market, Segment by Type:
1×96 Well
2×96 Well
Others
Global Fecal Calprotectin Test market, by Application
Hospitals
Diagnostic Laboratories
Academic & Research Institutes
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Fecal Calprotectin Test companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Fecal calprotectin test is a non-invasive clinical laboratory test that is used as a protein biomarker for the diagnosis of gastrointestinal disorders such as inflammatory bowel diseases, gastrointestinal infections, celiac disease, and colorectal cancer Calprotectin is a protein produced by the white blood cells. It is found in saliva, blood, stool, cerebrospinal fluid, and urine. Increase in level of calprotectin in stool is an indication of presence of gastrointestinal inflammation. Fecal calprotectin test is a quantitative measurement test that is usually carried out with the enzyme linked immunoassay (ELISA) technique. The test measures the level of inflammation in the bowel. Thus, it is inflammation specific and not disease specific. Fecal calprotectin test is primarily used as a protein biomarker in order to distinguish inflammatory bowel diseases such as Crohn s disease and ulcerative colitis from irritable bowel syndrome. This test also helps predict the relapse of the inflammatory bowel disease, therapeutic drug monitoring, and gastrointestinal disease prognosis.
The global Fecal Calprotectin Test market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Fecal Calprotectin Test in various end use industries. The expanding demands from the Hospitals, Diagnostic Laboratories, Academic & Research Institutes and Others, are propelling Fecal Calprotectin Test market. 1×96 Well, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 2×96 Well segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Fecal Calprotectin Test market, driven by demand from China, the second largest economy with some signs of stabilising, the Fecal Calprotectin Test market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Fecal Calprotectin Test, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Fecal Calprotectin Test market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Fecal Calprotectin Test market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Fecal Calprotectin Test sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Fecal Calprotectin Test covered in this report include Medixbiochemica, LifeSpan BioSciences, Inc, RayBiotech, Inc, Eagle Bioscience, Inc, Abbexa Ltd, Svar Life Science, Epitope Diagnostics, Inc and Alpha Laboratories, etc.
The global Fecal Calprotectin Test market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Medixbiochemica
LifeSpan BioSciences, Inc
RayBiotech, Inc
Eagle Bioscience, Inc
Abbexa Ltd
Svar Life Science
Epitope Diagnostics, Inc
Alpha Laboratories
Global Fecal Calprotectin Test market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Fecal Calprotectin Test market, Segment by Type:
1×96 Well
2×96 Well
Others
Global Fecal Calprotectin Test market, by Application
Hospitals
Diagnostic Laboratories
Academic & Research Institutes
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Fecal Calprotectin Test companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Fecal Calprotectin Test
1.1 Fecal Calprotectin Test Market Overview
1.1.1 Fecal Calprotectin Test Product Scope
1.1.2 Fecal Calprotectin Test Market Status and Outlook
1.2 Global Fecal Calprotectin Test Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Fecal Calprotectin Test Market Size by Region (2018-2029)
1.4 Global Fecal Calprotectin Test Historic Market Size by Region (2018-2023)
1.5 Global Fecal Calprotectin Test Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Fecal Calprotectin Test Market Size (2018-2029)
1.6.1 North America Fecal Calprotectin Test Market Size (2018-2029)
1.6.2 Europe Fecal Calprotectin Test Market Size (2018-2029)
1.6.3 Asia-Pacific Fecal Calprotectin Test Market Size (2018-2029)
1.6.4 Latin America Fecal Calprotectin Test Market Size (2018-2029)
1.6.5 Middle East & Africa Fecal Calprotectin Test Market Size (2018-2029)
2 Fecal Calprotectin Test Market by Type
2.1 Introduction
2.1.1 1×96 Well
2.1.2 2×96 Well
2.1.3 Others
2.2 Global Fecal Calprotectin Test Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Fecal Calprotectin Test Historic Market Size by Type (2018-2023)
2.2.2 Global Fecal Calprotectin Test Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Fecal Calprotectin Test Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Fecal Calprotectin Test Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Fecal Calprotectin Test Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Fecal Calprotectin Test Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Fecal Calprotectin Test Revenue Breakdown by Type (2018-2029)
3 Fecal Calprotectin Test Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Diagnostic Laboratories
3.1.3 Academic & Research Institutes
3.1.4 Others
3.2 Global Fecal Calprotectin Test Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Fecal Calprotectin Test Historic Market Size by Application (2018-2023)
3.2.2 Global Fecal Calprotectin Test Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Fecal Calprotectin Test Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Fecal Calprotectin Test Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Fecal Calprotectin Test Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Fecal Calprotectin Test Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Fecal Calprotectin Test Revenue Breakdown by Application (2018-2029)
4 Fecal Calprotectin Test Competition Analysis by Players
4.1 Global Fecal Calprotectin Test Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Fecal Calprotectin Test as of 2022)
4.3 Date of Key Players Enter into Fecal Calprotectin Test Market
4.4 Global Top Players Fecal Calprotectin Test Headquarters and Area Served
4.5 Key Players Fecal Calprotectin Test Product Solution and Service
4.6 Competitive Status
4.6.1 Fecal Calprotectin Test Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Medixbiochemica
5.1.1 Medixbiochemica Profile
5.1.2 Medixbiochemica Main Business
5.1.3 Medixbiochemica Fecal Calprotectin Test Products, Services and Solutions
5.1.4 Medixbiochemica Fecal Calprotectin Test Revenue (US$ Million) & (2018-2023)
5.1.5 Medixbiochemica Recent Developments
5.2 LifeSpan BioSciences, Inc
5.2.1 LifeSpan BioSciences, Inc Profile
5.2.2 LifeSpan BioSciences, Inc Main Business
5.2.3 LifeSpan BioSciences, Inc Fecal Calprotectin Test Products, Services and Solutions
5.2.4 LifeSpan BioSciences, Inc Fecal Calprotectin Test Revenue (US$ Million) & (2018-2023)
5.2.5 LifeSpan BioSciences, Inc Recent Developments
5.3 RayBiotech, Inc
5.3.1 RayBiotech, Inc Profile
5.3.2 RayBiotech, Inc Main Business
5.3.3 RayBiotech, Inc Fecal Calprotectin Test Products, Services and Solutions
5.3.4 RayBiotech, Inc Fecal Calprotectin Test Revenue (US$ Million) & (2018-2023)
5.3.5 Eagle Bioscience, Inc Recent Developments
5.4 Eagle Bioscience, Inc
5.4.1 Eagle Bioscience, Inc Profile
5.4.2 Eagle Bioscience, Inc Main Business
5.4.3 Eagle Bioscience, Inc Fecal Calprotectin Test Products, Services and Solutions
5.4.4 Eagle Bioscience, Inc Fecal Calprotectin Test Revenue (US$ Million) & (2018-2023)
5.4.5 Eagle Bioscience, Inc Recent Developments
5.5 Abbexa Ltd
5.5.1 Abbexa Ltd Profile
5.5.2 Abbexa Ltd Main Business
5.5.3 Abbexa Ltd Fecal Calprotectin Test Products, Services and Solutions
5.5.4 Abbexa Ltd Fecal Calprotectin Test Revenue (US$ Million) & (2018-2023)
5.5.5 Abbexa Ltd Recent Developments
5.6 Svar Life Science
5.6.1 Svar Life Science Profile
5.6.2 Svar Life Science Main Business
5.6.3 Svar Life Science Fecal Calprotectin Test Products, Services and Solutions
5.6.4 Svar Life Science Fecal Calprotectin Test Revenue (US$ Million) & (2018-2023)
5.6.5 Svar Life Science Recent Developments
5.7 Epitope Diagnostics, Inc
5.7.1 Epitope Diagnostics, Inc Profile
5.7.2 Epitope Diagnostics, Inc Main Business
5.7.3 Epitope Diagnostics, Inc Fecal Calprotectin Test Products, Services and Solutions
5.7.4 Epitope Diagnostics, Inc Fecal Calprotectin Test Revenue (US$ Million) & (2018-2023)
5.7.5 Epitope Diagnostics, Inc Recent Developments
5.8 Alpha Laboratories
5.8.1 Alpha Laboratories Profile
5.8.2 Alpha Laboratories Main Business
5.8.3 Alpha Laboratories Fecal Calprotectin Test Products, Services and Solutions
5.8.4 Alpha Laboratories Fecal Calprotectin Test Revenue (US$ Million) & (2018-2023)
5.8.5 Alpha Laboratories Recent Developments
6 North America
6.1 North America Fecal Calprotectin Test Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Fecal Calprotectin Test Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Fecal Calprotectin Test Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Fecal Calprotectin Test Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Fecal Calprotectin Test Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Fecal Calprotectin Test Market Dynamics
11.1 Fecal Calprotectin Test Industry Trends
11.2 Fecal Calprotectin Test Market Drivers
11.3 Fecal Calprotectin Test Market Challenges
11.4 Fecal Calprotectin Test Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
